▶ 調査レポート

クローン病診断・治療の世界市場2020年:企業別、地域別、種類・用途別

• 英文タイトル:Global Crohn's Disease Diagnostic and Therapeutic Market 2020 by Company, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。クローン病診断・治療の世界市場2020年:企業別、地域別、種類・用途別 / Global Crohn's Disease Diagnostic and Therapeutic Market 2020 by Company, Regions, Type and Application, Forecast to 2025 / D0GIR-01658資料のイメージです。• レポートコード:D0GIR-01658
• 出版社/出版日:GlobalInfoResearch / 2020年9月23日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、108ページ
• 納品方法:Eメール
• 産業分類:医療、製薬、バイオ
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、クローン病診断・治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。クローン病診断・治療の種類別市場規模(血液検査、糞便検査、大腸内視鏡検査、軟性S状結腸鏡検査、コンピュータ断層撮影、磁気共鳴画像、カプセル内視鏡検査)、用途別市場規模(クリニック、病院)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。
・市場概要
・企業情報(販売量、市場シェア、製品概要、SWOT分析):AbbVie、Salix Pharmaceuticals、Janssen Biotech、Celgene Corporation、Prometheus Laboratories、Genetech、Pfizer、Johnson & Johnson、Takeda's Pharmaceutical
・地域別グローバル市場分析 2015年-2020年
・クローン病診断・治療の北米市場(アメリカ、カナダ、メキシコ)
・クローン病診断・治療のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・クローン病診断・治療のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・クローン病診断・治療の南米市場(ブラジル、アルゼンチン)
・クローン病診断・治療の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:血液検査、糞便検査、大腸内視鏡検査、軟性S状結腸鏡検査、コンピュータ断層撮影、磁気共鳴画像、カプセル内視鏡検査
・用途別分析:クリニック、病院
・地域別市場規模予測 2021年-2025年
・調査の結果・結論

Market Overview
The global Crohn’s Disease Diagnostic and Therapeutic market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Crohn’s Disease Diagnostic and Therapeutic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Crohn’s Disease Diagnostic and Therapeutic market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Crohn’s Disease Diagnostic and Therapeutic market has been segmented into:
Blood Tests
Fecal Test
Colonoscopy
Flexible Sigmoidoscopy
Computerized Tomography
Magnetic Resonance Imaging
Capsule Endoscopy

By Application, Crohn’s Disease Diagnostic and Therapeutic has been segmented into:
Clinic
Hospital

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Crohn’s Disease Diagnostic and Therapeutic market presented in the report. This section sheds light on the sales growth of different regional and country-level Crohn’s Disease Diagnostic and Therapeutic markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Crohn’s Disease Diagnostic and Therapeutic market.

The report offers in-depth assessment of the growth and other aspects of the Crohn’s Disease Diagnostic and Therapeutic market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Crohn’s Disease Diagnostic and Therapeutic Market Share Analysis
Crohn’s Disease Diagnostic and Therapeutic competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Crohn’s Disease Diagnostic and Therapeutic sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Crohn’s Disease Diagnostic and Therapeutic sales, revenue and market share for each player covered in this report.

The major players covered in Crohn’s Disease Diagnostic and Therapeutic are:
AbbVie
Salix Pharmaceuticals
Janssen Biotech
Celgene Corporation
Prometheus Laboratories
Genetech
Pfizer
Johnson & Johnson
Takeda’s Pharmaceutical

レポート目次

Table of Contents

1 Crohn’s Disease Diagnostic and Therapeutic Market Overview
1.1 Product Overview and Scope of Crohn’s Disease Diagnostic and Therapeutic
1.2 Classification of Crohn’s Disease Diagnostic and Therapeutic by Type
1.2.1 Global Crohn’s Disease Diagnostic and Therapeutic Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Crohn’s Disease Diagnostic and Therapeutic Revenue Market Share by Type in 2019
1.2.3 Blood Tests
1.2.4 Fecal Test
1.2.5 Colonoscopy
1.2.6 Flexible Sigmoidoscopy
1.2.7 Computerized Tomography
1.2.8 Magnetic Resonance Imaging
1.2.9 Capsule Endoscopy
1.3 Global Crohn’s Disease Diagnostic and Therapeutic Market by Application
1.3.1 Overview: Global Crohn’s Disease Diagnostic and Therapeutic Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Clinic
1.3.3 Hospital
1.4 Global Crohn’s Disease Diagnostic and Therapeutic Market by Regions
1.4.1 Global Crohn’s Disease Diagnostic and Therapeutic Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Crohn’s Disease Diagnostic and Therapeutic (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Crohn’s Disease Diagnostic and Therapeutic Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Crohn’s Disease Diagnostic and Therapeutic Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Crohn’s Disease Diagnostic and Therapeutic Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Crohn’s Disease Diagnostic and Therapeutic Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Crohn’s Disease Diagnostic and Therapeutic Status and Prospect (2015-2025)
2 Company Profiles
2.1 AbbVie
2.1.1 AbbVie Details
2.1.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 AbbVie SWOT Analysis
2.1.4 AbbVie Product and Services
2.1.5 AbbVie Crohn’s Disease Diagnostic and Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.2 Salix Pharmaceuticals
2.2.1 Salix Pharmaceuticals Details
2.2.2 Salix Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Salix Pharmaceuticals SWOT Analysis
2.2.4 Salix Pharmaceuticals Product and Services
2.2.5 Salix Pharmaceuticals Crohn’s Disease Diagnostic and Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.3 Janssen Biotech
2.3.1 Janssen Biotech Details
2.3.2 Janssen Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Janssen Biotech SWOT Analysis
2.3.4 Janssen Biotech Product and Services
2.3.5 Janssen Biotech Crohn’s Disease Diagnostic and Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.4 Celgene Corporation
2.4.1 Celgene Corporation Details
2.4.2 Celgene Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Celgene Corporation SWOT Analysis
2.4.4 Celgene Corporation Product and Services
2.4.5 Celgene Corporation Crohn’s Disease Diagnostic and Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.5 Prometheus Laboratories
2.5.1 Prometheus Laboratories Details
2.5.2 Prometheus Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Prometheus Laboratories SWOT Analysis
2.5.4 Prometheus Laboratories Product and Services
2.5.5 Prometheus Laboratories Crohn’s Disease Diagnostic and Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.6 Genetech
2.6.1 Genetech Details
2.6.2 Genetech Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Genetech SWOT Analysis
2.6.4 Genetech Product and Services
2.6.5 Genetech Crohn’s Disease Diagnostic and Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.7 Pfizer
2.7.1 Pfizer Details
2.7.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Pfizer SWOT Analysis
2.7.4 Pfizer Product and Services
2.7.5 Pfizer Crohn’s Disease Diagnostic and Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.8 Johnson & Johnson
2.8.1 Johnson & Johnson Details
2.8.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Johnson & Johnson SWOT Analysis
2.8.4 Johnson & Johnson Product and Services
2.8.5 Johnson & Johnson Crohn’s Disease Diagnostic and Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.9 Takeda’s Pharmaceutical
2.9.1 Takeda’s Pharmaceutical Details
2.9.2 Takeda’s Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Takeda’s Pharmaceutical SWOT Analysis
2.9.4 Takeda’s Pharmaceutical Product and Services
2.9.5 Takeda’s Pharmaceutical Crohn’s Disease Diagnostic and Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Crohn’s Disease Diagnostic and Therapeutic Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Crohn’s Disease Diagnostic and Therapeutic Players Market Share
3.2.2 Top 10 Crohn’s Disease Diagnostic and Therapeutic Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Crohn’s Disease Diagnostic and Therapeutic Revenue and Market Share by Regions
4.2 North America Crohn’s Disease Diagnostic and Therapeutic Revenue and Growth Rate (2015-2020)
4.3 Europe Crohn’s Disease Diagnostic and Therapeutic Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Revenue and Growth Rate (2015-2020)
4.5 South America Crohn’s Disease Diagnostic and Therapeutic Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Revenue and Growth Rate (2015-2020)
5 North America Crohn’s Disease Diagnostic and Therapeutic Revenue by Countries
5.1 North America Crohn’s Disease Diagnostic and Therapeutic Revenue by Countries (2015-2020)
5.2 USA Crohn’s Disease Diagnostic and Therapeutic Revenue and Growth Rate (2015-2020)
5.3 Canada Crohn’s Disease Diagnostic and Therapeutic Revenue and Growth Rate (2015-2020)
5.4 Mexico Crohn’s Disease Diagnostic and Therapeutic Revenue and Growth Rate (2015-2020)
6 Europe Crohn’s Disease Diagnostic and Therapeutic Revenue by Countries
6.1 Europe Crohn’s Disease Diagnostic and Therapeutic Revenue by Countries (2015-2020)
6.2 Germany Crohn’s Disease Diagnostic and Therapeutic Revenue and Growth Rate (2015-2020)
6.3 UK Crohn’s Disease Diagnostic and Therapeutic Revenue and Growth Rate (2015-2020)
6.4 France Crohn’s Disease Diagnostic and Therapeutic Revenue and Growth Rate (2015-2020)
6.5 Russia Crohn’s Disease Diagnostic and Therapeutic Revenue and Growth Rate (2015-2020)
6.6 Italy Crohn’s Disease Diagnostic and Therapeutic Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Revenue by Countries
7.1 Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Revenue by Countries (2015-2020)
7.2 China Crohn’s Disease Diagnostic and Therapeutic Revenue and Growth Rate (2015-2020)
7.3 Japan Crohn’s Disease Diagnostic and Therapeutic Revenue and Growth Rate (2015-2020)
7.4 Korea Crohn’s Disease Diagnostic and Therapeutic Revenue and Growth Rate (2015-2020)
7.5 India Crohn’s Disease Diagnostic and Therapeutic Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Crohn’s Disease Diagnostic and Therapeutic Revenue and Growth Rate (2015-2020)
8 South America Crohn’s Disease Diagnostic and Therapeutic Revenue by Countries
8.1 South America Crohn’s Disease Diagnostic and Therapeutic Revenue by Countries (2015-2020)
8.2 Brazil Crohn’s Disease Diagnostic and Therapeutic Revenue and Growth Rate (2015-2020)
8.3 Argentina Crohn’s Disease Diagnostic and Therapeutic Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Crohn’s Disease Diagnostic and Therapeutic by Countries
9.1 Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Revenue by Countries (2015-2020)
9.2 Saudi Arabia Crohn’s Disease Diagnostic and Therapeutic Revenue and Growth Rate (2015-2020)
9.3 UAE Crohn’s Disease Diagnostic and Therapeutic Revenue and Growth Rate (2015-2020)
9.4 Egypt Crohn’s Disease Diagnostic and Therapeutic Revenue and Growth Rate (2015-2020)
9.5 South Africa Crohn’s Disease Diagnostic and Therapeutic Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Crohn’s Disease Diagnostic and Therapeutic Revenue and Market Share by Type (2015-2020)
10.2 Global Crohn’s Disease Diagnostic and Therapeutic Market Forecast by Type (2019-2024)
10.3 Blood Tests Revenue Growth Rate (2015-2025)
10.4 Fecal Test Revenue Growth Rate (2015-2025)
10.5 Colonoscopy Revenue Growth Rate (2015-2025)
10.6 Flexible Sigmoidoscopy Revenue Growth Rate (2015-2025)
10.7 Computerized Tomography Revenue Growth Rate (2015-2025)
10.8 Magnetic Resonance Imaging Revenue Growth Rate (2015-2025)
10.9 Capsule Endoscopy Revenue Growth Rate (2015-2025)
11 Global Crohn’s Disease Diagnostic and Therapeutic Market Segment by Application
11.1 Global Crohn’s Disease Diagnostic and Therapeutic Revenue Market Share by Application (2015-2020)
11.2 Crohn’s Disease Diagnostic and Therapeutic Market Forecast by Application (2019-2024)
11.3 Clinic Revenue Growth (2015-2020)
11.4 Hospital Revenue Growth (2015-2020)
12 Global Crohn’s Disease Diagnostic and Therapeutic Market Size Forecast (2021-2025)
12.1 Global Crohn’s Disease Diagnostic and Therapeutic Market Size Forecast (2021-2025)
12.2 Global Crohn’s Disease Diagnostic and Therapeutic Market Forecast by Regions (2021-2025)
12.3 North America Crohn’s Disease Diagnostic and Therapeutic Revenue Market Forecast (2021-2025)
12.4 Europe Crohn’s Disease Diagnostic and Therapeutic Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Crohn’s Disease Diagnostic and Therapeutic Revenue Market Forecast (2021-2025)
12.6 South America Crohn’s Disease Diagnostic and Therapeutic Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Crohn’s Disease Diagnostic and Therapeutic Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Crohn's Disease Diagnostic and Therapeutic Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Crohn's Disease Diagnostic and Therapeutic by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Crohn's Disease Diagnostic and Therapeutic Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Crohn's Disease Diagnostic and Therapeutic Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. AbbVie Corporate Information, Location and Competitors
Table 6. AbbVie Crohn's Disease Diagnostic and Therapeutic Major Business
Table 7. AbbVie Crohn's Disease Diagnostic and Therapeutic Total Revenue (USD Million) (2017-2018)
Table 8. AbbVie SWOT Analysis
Table 9. AbbVie Crohn's Disease Diagnostic and Therapeutic Product and Solutions
Table 10. AbbVie Crohn's Disease Diagnostic and Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Salix Pharmaceuticals Corporate Information, Location and Competitors
Table 12. Salix Pharmaceuticals Crohn's Disease Diagnostic and Therapeutic Major Business
Table 13. Salix Pharmaceuticals Crohn's Disease Diagnostic and Therapeutic Total Revenue (USD Million) (2018-2019)
Table 14. Salix Pharmaceuticals SWOT Analysis
Table 15. Salix Pharmaceuticals Crohn's Disease Diagnostic and Therapeutic Product and Solutions
Table 16. Salix Pharmaceuticals Crohn's Disease Diagnostic and Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Janssen Biotech Corporate Information, Location and Competitors
Table 18. Janssen Biotech Crohn's Disease Diagnostic and Therapeutic Major Business
Table 19. Janssen Biotech Crohn's Disease Diagnostic and Therapeutic Total Revenue (USD Million) (2017-2018)
Table 20. Janssen Biotech SWOT Analysis
Table 21. Janssen Biotech Crohn's Disease Diagnostic and Therapeutic Product and Solutions
Table 22. Janssen Biotech Crohn's Disease Diagnostic and Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Celgene Corporation Corporate Information, Location and Competitors
Table 24. Celgene Corporation Crohn's Disease Diagnostic and Therapeutic Major Business
Table 25. Celgene Corporation Crohn's Disease Diagnostic and Therapeutic Total Revenue (USD Million) (2017-2018)
Table 26. Celgene Corporation SWOT Analysis
Table 27. Celgene Corporation Crohn's Disease Diagnostic and Therapeutic Product and Solutions
Table 28. Celgene Corporation Crohn's Disease Diagnostic and Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Prometheus Laboratories Corporate Information, Location and Competitors
Table 30. Prometheus Laboratories Crohn's Disease Diagnostic and Therapeutic Major Business
Table 31. Prometheus Laboratories Crohn's Disease Diagnostic and Therapeutic Total Revenue (USD Million) (2017-2018)
Table 32. Prometheus Laboratories SWOT Analysis
Table 33. Prometheus Laboratories Crohn's Disease Diagnostic and Therapeutic Product and Solutions
Table 34. Prometheus Laboratories Crohn's Disease Diagnostic and Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Genetech Corporate Information, Location and Competitors
Table 36. Genetech Crohn's Disease Diagnostic and Therapeutic Major Business
Table 37. Genetech Crohn's Disease Diagnostic and Therapeutic Total Revenue (USD Million) (2017-2018)
Table 38. Genetech SWOT Analysis
Table 39. Genetech Crohn's Disease Diagnostic and Therapeutic Product and Solutions
Table 40. Genetech Crohn's Disease Diagnostic and Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Pfizer Corporate Information, Location and Competitors
Table 42. Pfizer Crohn's Disease Diagnostic and Therapeutic Major Business
Table 43. Pfizer Crohn's Disease Diagnostic and Therapeutic Total Revenue (USD Million) (2017-2018)
Table 44. Pfizer SWOT Analysis
Table 45. Pfizer Crohn's Disease Diagnostic and Therapeutic Product and Solutions
Table 46. Pfizer Crohn's Disease Diagnostic and Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Johnson & Johnson Corporate Information, Location and Competitors
Table 48. Johnson & Johnson Crohn's Disease Diagnostic and Therapeutic Major Business
Table 49. Johnson & Johnson Crohn's Disease Diagnostic and Therapeutic Total Revenue (USD Million) (2017-2018)
Table 50. Johnson & Johnson SWOT Analysis
Table 51. Johnson & Johnson Crohn's Disease Diagnostic and Therapeutic Product and Solutions
Table 52. Johnson & Johnson Crohn's Disease Diagnostic and Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Takeda's Pharmaceutical Corporate Information, Location and Competitors
Table 54. Takeda's Pharmaceutical Crohn's Disease Diagnostic and Therapeutic Major Business
Table 55. Takeda's Pharmaceutical Crohn's Disease Diagnostic and Therapeutic Total Revenue (USD Million) (2017-2018)
Table 56. Takeda's Pharmaceutical SWOT Analysis
Table 57. Takeda's Pharmaceutical Crohn's Disease Diagnostic and Therapeutic Product and Solutions
Table 58. Takeda's Pharmaceutical Crohn's Disease Diagnostic and Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Global Crohn's Disease Diagnostic and Therapeutic Revenue (Million USD) by Players (2015-2020)
Table 60. Global Crohn's Disease Diagnostic and Therapeutic Revenue Share by Players (2015-2020)
Table 61. Global Crohn's Disease Diagnostic and Therapeutic Revenue (Million USD) by Regions (2015-2020)
Table 62. Global Crohn's Disease Diagnostic and Therapeutic Revenue Market Share by Regions (2015-2020)
Table 63. North America Crohn's Disease Diagnostic and Therapeutic Revenue by Countries (2015-2020)
Table 64. North America Crohn's Disease Diagnostic and Therapeutic Revenue Market Share by Countries (2015-2020)
Table 65. Europe Crohn's Disease Diagnostic and Therapeutic Revenue (Million USD) by Countries (2015-2020)
Table 66. Asia-Pacific Crohn's Disease Diagnostic and Therapeutic Revenue (Million USD) by Countries (2015-2020)
Table 67. South America Crohn's Disease Diagnostic and Therapeutic Revenue by Countries (2015-2020)
Table 68. South America Crohn's Disease Diagnostic and Therapeutic Revenue Market Share by Countries (2015-2020)
Table 69. Middle East and Africa Crohn's Disease Diagnostic and Therapeutic Revenue (Million USD) by Countries (2015-2020)
Table 70. Middle East and Africa Crohn's Disease Diagnostic and Therapeutic Revenue Market Share by Countries (2015-2020)
Table 71. Global Crohn's Disease Diagnostic and Therapeutic Revenue (Million USD) by Type (2015-2020)
Table 72. Global Crohn's Disease Diagnostic and Therapeutic Revenue Share by Type (2015-2020)
Table 73. Global Crohn's Disease Diagnostic and Therapeutic Revenue Forecast by Type (2021-2025)
Table 74. Global Crohn's Disease Diagnostic and Therapeutic Revenue by Application (2015-2020)
Table 75. Global Crohn's Disease Diagnostic and Therapeutic Revenue Share by Application (2015-2020)
Table 76. Global Crohn's Disease Diagnostic and Therapeutic Revenue Forecast by Application (2021-2025)
Table 77. Global Crohn's Disease Diagnostic and Therapeutic Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Crohn's Disease Diagnostic and Therapeutic Picture
Figure 2. Global Crohn's Disease Diagnostic and Therapeutic Revenue Market Share by Type in 2019
Figure 3. Blood Tests Picture
Figure 4. Fecal Test Picture
Figure 5. Colonoscopy Picture
Figure 6. Flexible Sigmoidoscopy Picture
Figure 7. Computerized Tomography Picture
Figure 8. Magnetic Resonance Imaging Picture
Figure 9. Capsule Endoscopy Picture
Figure 10. Crohn's Disease Diagnostic and Therapeutic Revenue Market Share by Application in 2019
Figure 11. Clinic Picture
Figure 12. Hospital Picture
Figure 13. Global Crohn's Disease Diagnostic and Therapeutic Revenue (USD Million) and Growth Rate (2015-2025)
Figure 14. North America Crohn's Disease Diagnostic and Therapeutic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Europe Crohn's Disease Diagnostic and Therapeutic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Asia-Pacific Crohn's Disease Diagnostic and Therapeutic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. South America Crohn's Disease Diagnostic and Therapeutic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Middle East and Africa Crohn's Disease Diagnostic and Therapeutic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Crohn's Disease Diagnostic and Therapeutic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Global Crohn's Disease Diagnostic and Therapeutic Revenue Share by Players in 2019
Figure 21. Global Top 5 Players Crohn's Disease Diagnostic and Therapeutic Revenue Market Share in 2019
Figure 22. Global Top 10 Players Crohn's Disease Diagnostic and Therapeutic Revenue Market Share in 2019
Figure 23. Key Players Market Share Trend
Figure 24. Global Crohn's Disease Diagnostic and Therapeutic Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 25. Global Crohn's Disease Diagnostic and Therapeutic Revenue Market Share by Regions (2015-2020)
Figure 26. Global Crohn's Disease Diagnostic and Therapeutic Revenue Market Share by Regions in 2018
Figure 27. North America Crohn's Disease Diagnostic and Therapeutic Revenue and Growth Rate (2015-2020)
Figure 28. Europe Crohn's Disease Diagnostic and Therapeutic Revenue and Growth Rate (2015-2020)
Figure 29. Asia-Pacific Crohn's Disease Diagnostic and Therapeutic Revenue and Growth Rate (2015-2020)
Figure 30. South America Crohn's Disease Diagnostic and Therapeutic Revenue and Growth Rate (2015-2020)
Figure 31. Middle East and Africa Crohn's Disease Diagnostic and Therapeutic Revenue and Growth Rate (2015-2020)
Figure 32. North America Crohn's Disease Diagnostic and Therapeutic Revenue Market Share by Countries (2015-2020)
Figure 33. North America Crohn's Disease Diagnostic and Therapeutic Revenue Market Share by Countries in 2019
Figure 34. USA Crohn's Disease Diagnostic and Therapeutic Revenue and Growth Rate (2015-2020)
Figure 35. Canada Crohn's Disease Diagnostic and Therapeutic Revenue and Growth Rate (2015-2020)
Figure 36. Mexico Crohn's Disease Diagnostic and Therapeutic Revenue and Growth Rate (2015-2020)
Figure 37. Europe Crohn's Disease Diagnostic and Therapeutic Revenue Market Share by Countries (2015-2020)
Figure 38. Europe Crohn's Disease Diagnostic and Therapeutic Revenue Market Share by Countries in 2019
Figure 39. Germany Crohn's Disease Diagnostic and Therapeutic Revenue and Growth Rate (2015-2020)
Figure 40. UK Crohn's Disease Diagnostic and Therapeutic Revenue and Growth Rate (2015-2020)
Figure 41. France Crohn's Disease Diagnostic and Therapeutic Revenue and Growth Rate (2015-2020)
Figure 42. Russia Crohn's Disease Diagnostic and Therapeutic Revenue and Growth Rate (2015-2020)
Figure 43. Italy Crohn's Disease Diagnostic and Therapeutic Revenue and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Crohn's Disease Diagnostic and Therapeutic Revenue Market Share by Countries (2015-2020)
Figure 45. Asia-Pacific Crohn's Disease Diagnostic and Therapeutic Revenue Market Share by Countries in 2019
Figure 46. China Crohn's Disease Diagnostic and Therapeutic Revenue and Growth Rate (2015-2020)
Figure 47. Japan Crohn's Disease Diagnostic and Therapeutic Revenue and Growth Rate (2015-2020)
Figure 48. Korea Crohn's Disease Diagnostic and Therapeutic Revenue and Growth Rate (2015-2020)
Figure 49. India Crohn's Disease Diagnostic and Therapeutic Revenue and Growth Rate (2015-2020)
Figure 50. Southeast Asia Crohn's Disease Diagnostic and Therapeutic Revenue and Growth Rate (2015-2020)
Figure 51. South America Crohn's Disease Diagnostic and Therapeutic Revenue Market Share by Countries (2015-2020)
Figure 52. South America Crohn's Disease Diagnostic and Therapeutic Revenue Market Share by Countries in 2019
Figure 53. Brazil Crohn's Disease Diagnostic and Therapeutic Revenue and Growth Rate (2015-2020)
Figure 54. Argentina Crohn's Disease Diagnostic and Therapeutic Revenue and Growth Rate (2015-2020)
Figure 55. Middle East and Africa Crohn's Disease Diagnostic and Therapeutic Revenue Market Share by Countries (2015-2020)
Figure 56. Middle East and Africa Crohn's Disease Diagnostic and Therapeutic Revenue Market Share by Countries in 2019
Figure 57. Saudi Arabia Crohn's Disease Diagnostic and Therapeutic Revenue and Growth Rate (2015-2020)
Figure 58. UAE Crohn's Disease Diagnostic and Therapeutic Revenue and Growth Rate (2015-2020)
Figure 59. Egypt Crohn's Disease Diagnostic and Therapeutic Revenue and Growth Rate (2015-2020)
Figure 60. South Africa Crohn's Disease Diagnostic and Therapeutic Revenue and Growth Rate (2015-2020)
Figure 61. Global Crohn's Disease Diagnostic and Therapeutic Revenue Share by Type (2015-2020)
Figure 62. Global Crohn's Disease Diagnostic and Therapeutic Revenue Share by Type in 2019
Figure 63. Global Crohn's Disease Diagnostic and Therapeutic Market Share Forecast by Type (2021-2025)
Figure 64. Global Blood Tests Revenue Growth Rate (2015-2020)
Figure 65. Global Fecal Test Revenue Growth Rate (2015-2020)
Figure 66. Global Colonoscopy Revenue Growth Rate (2015-2020)
Figure 67. Global Flexible Sigmoidoscopy Revenue Growth Rate (2015-2020)
Figure 68. Global Computerized Tomography Revenue Growth Rate (2015-2020)
Figure 69. Global Magnetic Resonance Imaging Revenue Growth Rate (2015-2020)
Figure 70. Global Capsule Endoscopy Revenue Growth Rate (2015-2020)
Figure 71. Global Crohn's Disease Diagnostic and Therapeutic Revenue Share by Application (2015-2020)
Figure 72. Global Crohn's Disease Diagnostic and Therapeutic Revenue Share by Application in 2019
Figure 73. Global Crohn's Disease Diagnostic and Therapeutic Market Share Forecast by Application (2021-2025)
Figure 74. Global Clinic Revenue Growth Rate (2015-2020)
Figure 75. Global Hospital Revenue Growth Rate (2015-2020)
Figure 76. Global Crohn's Disease Diagnostic and Therapeutic Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 77. Global Crohn's Disease Diagnostic and Therapeutic Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 78. Global Crohn's Disease Diagnostic and Therapeutic Revenue Market Share Forecast by Regions (2021-2025)
Figure 79. North America Crohn's Disease Diagnostic and Therapeutic Revenue Market Forecast (2021-2025)
Figure 80. Europe Crohn's Disease Diagnostic and Therapeutic Revenue Market Forecast (2021-2025)
Figure 81. Asia-Pacific Crohn's Disease Diagnostic and Therapeutic Revenue Market Forecast (2021-2025)
Figure 82. South America Crohn's Disease Diagnostic and Therapeutic Revenue Market Forecast (2021-2025)
Figure 83. Middle East and Africa Crohn's Disease Diagnostic and Therapeutic Revenue Market Forecast (2021-2025)
Figure 84. Sales Channel: Direct Channel vs Indirect Channel